Clinical Trials List
Protocol NumberTLCe01B4013
Not yet recruiting
2016-11-04 - 2018-12-31
Phase IV
Terminated1
-
Trial Applicant
TAIWAN LIPOSOME CO., LTD.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
80 participants
